Cargando…
Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase
Metformin, the most widely administered oral anti-diabetic therapeutic agent, exerts its glucose-lowering effect predominantly via liver kinase B1 (LKB1)-dependent activation of adenosine monophosphate-activated protein kinase (AMPK). Accumulating evidence has demonstrated that metformin possesses p...
Autores principales: | GUO, QIANQIAN, LIU, ZHIYAN, JIANG, LILI, LIU, MENGJIE, MA, JIEQUN, YANG, CHENGCHENG, HAN, LILI, NAN, KEJUN, LIANG, XUAN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768996/ https://www.ncbi.nlm.nih.gov/pubmed/26847819 http://dx.doi.org/10.3892/mmr.2016.4830 |
Ejemplares similares
-
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase
por: Seneviratne, Anusha, et al.
Publicado: (2020) -
Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase
por: Tsai, Wei-Lun, et al.
Publicado: (2017) -
Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy
por: Liu, Mengjie, et al.
Publicado: (2018) -
Roles of adenosine monophosphate-activated protein kinase (AMPK) in the kidney
por: Zhu, Na, et al.
Publicado: (2022)